EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19

Tin Van Huynh, Lekha Rethi, Ting-Wei Lee iD, Satoshi Higa iD, Yu-Hsun Kao, Yi-Jen Chen iD

Cells · 11.03.2023 · 12 (6) · 877

DOI: 10.3390/cells12060877 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 11.03.2023. Verfasst von Tin Van Huynh und 5 weiteren Autor:innen. Beteiligte Einrichtung: International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan. Hauptthemen laut MEDLINE: Myocytes, Cardiac, COVID-19. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of Taiwan, Wan Fang Hospital, Foundation for the Development of Internal Medicine in Okinawa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

COVID-19 has a major impact on cardiovascular diseases and may lead to myocarditis or cardiac failure. The clove-like spike (S) protein of SARS-CoV-2 facilitates its transmission and pathogenesis. Cardiac mitochondria produce energy for key heart functions. We hypothesized that S1 would directly impair the functions of cardiomyocyte mitochondria, thus causing cardiac dysfunction.

Methods

Through the Seahorse Mito Stress Test and real-time ATP rate assays, we explored the mitochondrial bioenergetics in human cardiomyocytes (AC16). The cells were treated without (control) or with S1 (1 nM) for 24, 48, and 72 h and we observed the mitochondrial morphology using transmission electron microscopy and confocal fluorescence microscopy. Western blotting, XRhod-1, and MitoSOX Red staining were performed to evaluate the expression of proteins related to energetic metabolism and relevant signaling cascades, mitochondrial Ca2+ levels, and ROS production.

Results

The 24 h S1 treatment increased ATP production and mitochondrial respiration by increasing the expression of fatty-acid-transporting regulators and inducing more negative mitochondrial membrane potential (Δψm). The 72 h S1 treatment decreased mitochondrial respiration rates and Δψm, but increased levels of reactive oxygen species (ROS), mCa2+, and intracellular Ca2+. Electron microscopy revealed increased mitochondrial fragmentation/fission in AC16 cells treated for 72 h. The effects of S1 on ATP production were completely blocked by neutralizing ACE2 but not CD147 antibodies, and were partly attenuated by Mitotempo (1 µM).

Conclusion

S1 might impair mitochondrial function in human cardiomyocytes by altering Δψm, mCa2+ overload, ROS accumulation, and mitochondrial dynamics via ACE2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacCOVID-19RatsAnimalsHumansReactive Oxygen SpeciesRats, Sprague-DawleyAngiotensin-Converting Enzyme 2Spike Glycoprotein, CoronavirusSARS-CoV-2Mitochondria, HeartAdenosine Triphosphate

Stichwörter der Autor:innen

cardiac dysfunctionmitochondrial dynamicsoxygen consumption ratereactive oxygen speciesspike protein

Substanzen

Reactive Oxygen Speciesspike protein, SARS-CoV-2Angiotensin-Converting Enzyme 2Spike Glycoprotein, CoronavirusAdenosine Triphosphate

Autor:innen und Institutionen

  • International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • School of Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei 11031, Taiwan.
  • International Ph.D. Program for Biomedical Engineering, Taipei Medical University, Taipei 11031, Taiwan.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.
  • Cardiac Electrophysiology and Pacing Laboratory, Division of Cardiovascular Medicine, Makiminato Central Hospital, Okinawa 901-2131, Japan.

ORCID-Profile: Ting-Wei Lee, Satoshi Higa, Yi-Jen Chen

Förderung

  • Ministry of Science and Technology of Taiwan
  • Wan Fang Hospital
  • Foundation for the Development of Internal Medicine in Okinawa

Zitieren

APA

Huynh, T. V., Rethi, L., Lee, T. W., Higa, S., Kao, Y. H., & Chen, Y. J. (2023). Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19. Cells, 12(6), 877. https://doi.org/10.3390/cells12060877

Vancouver

Huynh TV, Rethi L, Lee TW, Higa S, Kao YH, Chen YJ. Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19. Cells. 2023;12(6):877. doi:10.3390/cells12060877

BibTeX
@article{Huynh2023,
  author = {Huynh, Tin Van and Rethi, Lekha and Lee, Ting-Wei and Higa, Satoshi and Kao, Yu-Hsun and Chen, Yi-Jen},
  title = {Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {6},
  pages = {877},
  doi = {10.3390/cells12060877}
}
Kostenlos starten →